Glycolytic enzyme activities in breast cancer metastases - PubMed (original) (raw)
Glycolytic enzyme activities in breast cancer metastases
A Hennipman et al. Tumour Biol. 1988.
Abstract
The activities of hexokinase, phosphofructokinase, aldolase, enolase and pyruvate kinase were studied in breast cancer metastases occurring at various sites and compared with the enzyme activities in a series of primary breast cancers. The activities of all enzymes studied were significantly higher in the metastases compared to the primary tumors (p less than or equal to 0.05). However, no changes in the isoenzyme patterns of enolase and pyruvate kinase were observed when the metastases were compared with primary breast cancers. Differences in location of the metastases did not lead to differences in enzyme activities. Our data suggest an association of an increasing rate of glycolysis with tumor progression.
Similar articles
- Heterogeneity of glycolytic enzyme activity and isozyme composition of pyruvate kinase in breast cancer.
Hennipman A, van Oirschot BA, Smits J, Rijksen G, Staal GE. Hennipman A, et al. Tumour Biol. 1988;9(4):178-89. doi: 10.1159/000217560. Tumour Biol. 1988. PMID: 2971267 - Response of rat cerebral glycolytic enzymes to hyperammonemic states.
Ratnakumari L, Murthy CR. Ratnakumari L, et al. Neurosci Lett. 1993 Oct 14;161(1):37-40. doi: 10.1016/0304-3940(93)90134-7. Neurosci Lett. 1993. PMID: 8255543 - [Activity of some glycolytic enzymes in frog muscles].
Thibert P, Nicolet M. Thibert P, et al. C R Seances Soc Biol Fil. 1974;168(10-11-12):1260-8. C R Seances Soc Biol Fil. 1974. PMID: 4283081 French. No abstract available. - Magnesium regulation of the glycolytic pathway and the enzymes involved.
Garfinkel L, Garfinkel D. Garfinkel L, et al. Magnesium. 1985;4(2-3):60-72. Magnesium. 1985. PMID: 2931560 Review. - X-ray studies of glycolytic enzymes.
Blake CC. Blake CC. Essays Biochem. 1975;11:37-79. Essays Biochem. 1975. PMID: 174910 Review. No abstract available.
Cited by
- Three are better than one: plasminogen receptors as cancer theranostic targets.
Ceruti P, Principe M, Capello M, Cappello P, Novelli F. Ceruti P, et al. Exp Hematol Oncol. 2013 Apr 17;2(1):12. doi: 10.1186/2162-3619-2-12. Exp Hematol Oncol. 2013. PMID: 23594883 Free PMC article. - Restorative effect of Kalpaamruthaa, an indigenous preparation, on oxidative damage in mammary gland mitochondrial fraction in experimental mammary carcinoma.
Arulkumaran S, Ramprasath VR, Shanthi P, Sachdanandam P. Arulkumaran S, et al. Mol Cell Biochem. 2006 Oct;291(1-2):77-82. doi: 10.1007/s11010-006-9199-2. Epub 2006 Sep 5. Mol Cell Biochem. 2006. PMID: 16953336 - Overexpression of α-enolase correlates with poor survival in canine mammary carcinoma.
Chu PY, Hsu NC, Liao AT, Shih NY, Hou MF, Liu CH. Chu PY, et al. BMC Vet Res. 2011 Oct 21;7:62. doi: 10.1186/1746-6148-7-62. BMC Vet Res. 2011. PMID: 22014164 Free PMC article. - Emerging metabolic targets in the therapy of hematological malignancies.
Leni Z, Parakkal G, Arcaro A. Leni Z, et al. Biomed Res Int. 2013;2013:946206. doi: 10.1155/2013/946206. Epub 2013 Aug 18. Biomed Res Int. 2013. PMID: 24024216 Free PMC article. Review. - The increment in standardized uptake value determined using dual-phase 18F-FDG PET is a promising prognostic factor in non-small-cell lung cancer.
Chen HH, Lee BF, Su WC, Lai YH, Chen HY, Guo HR, Yao WJ, Chiu NT. Chen HH, et al. Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1478-85. doi: 10.1007/s00259-013-2452-5. Epub 2013 Jun 7. Eur J Nucl Med Mol Imaging. 2013. PMID: 23744342
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical